NMT 📈 Nuveen Massachusetts - Overview
Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US67061E1047 • Muni Massachusetts
NMT: Municipal Bonds, Government Securities
Additional Sources for NMT Fund
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NMT Fund Overview
| Market Cap in USD | 113m |
| Style | Muni Massachusetts |
| TER | 1.50% |
| IPO / Inception | 1993-03-18 |
NMT Fund Ratings
| Growth 5y | -2.95% |
| Fundamental | - |
| Dividend | 39.2% |
| Rel. Strength Industry | -41.4 |
| Analysts | - |
| Fair Price Momentum | 11.71 USD |
| Fair Price DCF | - |
NMT Dividends
| Dividend Yield 12m | 5.33% |
| Yield on Cost 5y | 5.29% |
| Annual Growth 5y | -8.13% |
| Payout Consistency | 92.3% |
NMT Growth Ratios
| Growth Correlation 3m | 52.4% |
| Growth Correlation 12m | 95.2% |
| Growth Correlation 5y | -55% |
| CAGR 5y | -0.17% |
| CAGR/Mean DD 5y | -0.01 |
| Sharpe Ratio 12m | 1.26 |
| Alpha | 4.98 |
| Beta | 0.31 |
| Volatility | 8.76% |
| Current Volume | 32.5k |
| Average Volume 20d | 33.9k |
What is the price of NMT stocks?
As of December 22, 2024, the stock is trading at USD 11.51 with a total of 32,527 shares traded.
Over the past week, the price has changed by -1.20%, over one month by -0.60%, over three months by +2.24% and over the past year by +16.08%.
As of December 22, 2024, the stock is trading at USD 11.51 with a total of 32,527 shares traded.
Over the past week, the price has changed by -1.20%, over one month by -0.60%, over three months by +2.24% and over the past year by +16.08%.
Is Nuveen Massachusetts a good stock to buy?
Neither. Based on ValueRay Analyses, Nuveen Massachusetts is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -2.95 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NMT as of December 2024 is 11.71. This means that NMT is currently overvalued and has a potential downside of 1.74%.
Neither. Based on ValueRay Analyses, Nuveen Massachusetts is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -2.95 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NMT as of December 2024 is 11.71. This means that NMT is currently overvalued and has a potential downside of 1.74%.
Is NMT a buy, sell or hold?
Nuveen Massachusetts has no consensus analysts rating.
Nuveen Massachusetts has no consensus analysts rating.
What are the forecast for NMT stock price target?
According to ValueRays Forecast Model, NMT Nuveen Massachusetts will be worth about 12.7 in December 2025. The stock is currently trading at 11.51. This means that the stock has a potential upside of +10.69%.
According to ValueRays Forecast Model, NMT Nuveen Massachusetts will be worth about 12.7 in December 2025. The stock is currently trading at 11.51. This means that the stock has a potential upside of +10.69%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 12.7 | 10.7% |